Bliss
BLISSGVS.NSBliss GVS Pharma Price (BLISSGVS.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
106,071,737
(0.5621)%Revenue and Profitability
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 623,392,000 | 1,023,959,000 | 1,329,557,000 | 1,688,753,000 | 2,188,381,000 | 2,666,749,000 | 3,966,254,000 | 3,468,684,000 | 4,071,344,000 | 5,468,941,000 | 7,997,409,000 | 3,638,245,000 | 8,861,094,000 | 6,819,100,000 | 5,686,875,000 | 7,379,285,000 | 7,515,875,000 | 7,659,076,000 |
| Net Income | 38,408,776 | 337,353,000 | 374,512,000 | 417,215,000 | 406,303,000 | 525,358,000 | 577,201,000 | 409,917,000 | 599,097,000 | 824,826,000 | 856,106,000 | 587,853,000 | 1,237,216,000 | 972,650,000 | 684,909,000 | 150,402,000 | 708,588,000 | 754,541,000 |
| FCF USD | -22,917,000 | -30,528,000 | 49,237,000 | 23,747,000 | 131,489,000 | 131,238,000 | -133,327,000 | 249,037,000 | 93,339,000 | 996,372,000 | 1,360,937,000 | -105,779,000 | -38,185,000 | -150,353,000 | 548,452,000 | 614,775,000 | -594,855,000 | 1,241,193,000 |
| OCF USD | 4,474,000 | -9,781,000 | 183,135,000 | 68,961,000 | 236,575,000 | 363,786,000 | 58,719,000 | 823,128,000 | 489,370,000 | 1,129,465,000 | 2,878,564,000 | 176,393,000 | 399,500,000 | 452,796,000 | 639,694,000 | 1,354,806,000 | 343,135,000 | 1,524,486,000 |
Financial Health - DEBT
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.10 | 0.06 | 0.06 | 0.16 | 0.47 | 0.91 | 1.24 | 0.60 | 0.26 | 0.14 | 0.03 | 0.20 | 0.31 | 0.33 | 0.21 | 0.41 | 0.59 |
| D/E | 0.32 | 0.06 | 0.02 | 0.06 | 0.05 | 0.18 | 0.60 | 0.50 | 0.35 | 0.24 | 0.39 | 0.22 | 0.16 | 0.17 | 0.15 | 0.13 | 0.12 | 0.10 |
| CA/CL | 1.59 | 3.02 | 3.88 | 7.44 | 4.76 | 3.54 | 1.73 | 1.86 | 1.72 | 1.77 | 1.40 | 2.30 | 3.35 | 3.33 | 3.76 | 3.33 | 3.61 | 5.08 |
| TA/TL | 1.69 | 3.14 | 4.32 | 6.16 | 4.55 | 3.13 | 1.87 | 2.04 | 2.13 | 2.41 | 2.25 | 2.75 | 3.69 | 3.69 | 4.33 | 4.23 | 4.83 | 5.76 |
| Total Debt | 76,317,000 | 34,956,000 | 24,147,000 | 76,421,000 | 82,394,000 | 376,293,000 | 1,552,568,000 | 1,446,373,000 | 1,183,002,000 | 1,003,665,000 | 1,870,547,000 | 1,179,540,000 | 1,019,396,000 | 1,261,265,000 | 1,218,995,000 | 1,093,908,000 | 1,018,978,000 | 998,401,000 |
Management Performance
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIC | 13.70% | 53.43% | 39.37% | 30.94% | 24.18% | 21.57% | 13.15% | 7.66% | 14.51% | 19.90% | 15.91% | 8.50% | 13.71% | 9.30% | 6.61% | 4.51% | 7.00% | 7.75% |
| ROE | 16.32% | 54.52% | 38.40% | 31.32% | 24.38% | 24.94% | 22.37% | 14.29% | 17.77% | 19.99% | 17.72% | 10.96% | 19.15% | 13.22% | 8.47% | 1.84% | 8.02% | 7.80% |
| ROA | 0.00% | 38.82% | 31.72% | 28.77% | 24.82% | 25.64% | 18.71% | 12.11% | 14.50% | 19.45% | 18.17% | 20.87% | 20.10% | 12.53% | 9.67% | 11.52% | 9.17% | 6.22% |
| NM % | 6.16% | 32.95% | 28.17% | 24.71% | 18.57% | 19.70% | 14.55% | 11.82% | 14.71% | 15.08% | 10.70% | 16.16% | 13.96% | 14.26% | 12.04% | 2.04% | 9.43% | 9.85% |
| FCF / R% | 0.00% | -2.98% | 3.70% | 1.41% | 6.01% | 4.92% | -3.36% | 7.18% | 2.29% | 18.22% | 17.02% | -2.91% | -0.43% | -2.20% | 9.64% | 8.33% | -7.91% | 16.21% |
| FCF / NI% | -39.08% | -8.66% | 12.23% | 5.19% | 24.82% | 16.52% | -12.18% | 35.30% | 9.72% | 67.23% | 75.95% | -5.89% | -2.10% | -11.66% | 52.67% | 48.12% | -56.08% | 164.50% |
| Operating Margin (OM) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.53 | 0.69 | 0.70 | 0.65 | 0.54 | 1.31 | 0.66 | 0.99 | 1.30 | 1.01 | 1.08 | 1.16 |
Per Share
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | 6.53 | 2.04 | 3.63 | 4.04 | 3.94 | 5.09 | 5.60 | 3.97 | 5.81 | 8.00 | 8.30 | 5.70 | 11.99 | 9.43 | 6.64 | 1.46 | 6.83 | 7.23 |
| SPS | 105.97 | 6.20 | 12.89 | 16.37 | 21.22 | 25.85 | 38.45 | 33.63 | 39.47 | 53.02 | 77.53 | 35.27 | 85.91 | 66.11 | 55.13 | 71.41 | 72.40 | 73.39 |
| OCPS | 0.76 | -0.06 | 1.78 | 0.67 | 2.29 | 3.53 | 0.57 | 7.98 | 4.74 | 10.95 | 27.91 | 1.71 | 3.87 | 4.39 | 6.20 | 13.11 | 3.31 | 14.61 |
| FCPS | -3.90 | -0.18 | 0.48 | 0.23 | 1.27 | 1.27 | -1.29 | 2.41 | 0.90 | 9.66 | 13.19 | -1.03 | -0.37 | -1.46 | 5.32 | 5.95 | -5.73 | 11.89 |
| BVPS | 40.00 | 3.75 | 9.45 | 12.91 | 16.15 | 20.42 | 26.35 | 28.80 | 34.12 | 43.21 | 53.14 | 53.10 | 63.97 | 72.75 | 80.27 | 81.91 | 88.38 | 96.11 |
Per Share - CAGR
| Year | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 6.53 | 2.04 | 3.63 | 4.04 | 3.94 | 5.09 | 5.60 | 3.97 | 5.81 | 8.00 | 8.30 | 5.70 | 11.99 | 9.43 | 6.64 | 1.46 | 6.83 | 7.23 |
| CAGR-SPS | 105.97 | 6.20 | 12.89 | 16.37 | 21.22 | 25.85 | 38.45 | 33.63 | 39.47 | 53.02 | 77.53 | 35.27 | 85.91 | 66.11 | 55.13 | 71.41 | 72.40 | 73.39 |
| CAGR-OCPS | 0.76 | -0.06 | 1.78 | 0.67 | 2.29 | 3.53 | 0.57 | 7.98 | 4.74 | 10.95 | 27.91 | 1.71 | 3.87 | 4.39 | 6.20 | 13.11 | 3.31 | 14.61 |
| CAGR-FCPS | -3.90 | -0.18 | 0.48 | 0.23 | 1.27 | 1.27 | -1.29 | 2.41 | 0.90 | 9.66 | 13.19 | -1.03 | -0.37 | -1.46 | 5.32 | 5.95 | -5.73 | 11.89 |
| CAGR-BVPS | 40.00 | 3.75 | 9.45 | 12.91 | 16.15 | 20.42 | 26.35 | 28.80 | 34.12 | 43.21 | 53.14 | 53.10 | 63.97 | 72.75 | 80.27 | 81.91 | 88.38 | 96.11 |